Junyent, M <br/><br/>
ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study.  [electronic resource] 

 -  Nutrition, metabolism, and cardiovascular diseases : NMCD  Dec 2010 
 - 698-705 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1590-3729 
<br/><br/><label>Standard No.: </label>10.1016/j.numecd.2009.06.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADAM Proteins--genetics<br/>ADAM17 Protein<br/>Adipocytes--metabolism<br/>Adult<br/>Aged<br/>Alleles<br/>Body Mass Index<br/>Cholesterol, HDL--blood<br/>Diet<br/>Dietary Fats, Unsaturated--metabolism<br/>Fatty Acids, Omega-6--metabolism<br/>Female<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Humans<br/>Insulin--blood<br/>Insulin Resistance<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Obesity--genetics<br/>Polymorphism, Single Nucleotide